DNV001 Injection in Patients With Hypercholesterolemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.
Also called NCT07391722
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Hangzhou Dinovate Biotech Co., Ltd
- Registry
-
NCT07391722
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07391722. Randomized; quadruple masking; primary purpose treatment. Start 2026-02-05 (anticipated); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DNV001 Injection in Patients With Hypercholesterolemia
- Acronym
- DNV001
- Condition
- Primary Hypercholesterolemia
- Intervention (Biological)
- DNV001 Injection
- Intervention (Biological)
- Placebo
- Lead sponsor
- Hangzhou Dinovate Biotech Co., Ltd
Record details
- Record id
cardio:ct-nct07391722- Content hash
34b89ca1697395522627f310a8d188d2417fe12c28b5b44bfadf0faf30a315c8